Equity (Issuance of Stock and Forward Sale Agreement) (Details) $ in Millions |
1 Months Ended | 12 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
Oct. 26, 2020
shares
|
Sep. 14, 2020
shares
|
Nov. 30, 2017
USD ($)
|
Dec. 31, 2020
USD ($)
shares
|
Dec. 31, 2019
shares
|
Dec. 31, 2018
shares
|
Dec. 31, 2017
USD ($)
|
|
| Class of Stock [Line Items] | |||||||
| Antidilutive securities (in shares) | shares | 27,100,000 | 3,000,000.0 | 500,000 | ||||
| Common stock, authorized (in shares) | shares | 3,200,000,000 | 800,000,000 | 3,200,000,000 | 3,200,000,000 | |||
| Stockholders' Equity Note, Stock Split, Conversion Ratio | 4 | 4 | |||||
| NEP [Member] | |||||||
| Class of Stock [Line Items] | |||||||
| Senior unsecured convertible notes outstanding | $ | $ 600 | $ 300 | |||||
| Series A Convertible Preferred Units [Member] | NEP [Member] | |||||||
| Class of Stock [Line Items] | |||||||
| Stock sold during the period | $ | $ 550 | ||||||